Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,275 Followers

Arbutus Biopharma (ABUS) Ownership Overview

0.05% Insiders

9.73% Mutual Funds

28.16% Other Institutional Investors

10.48% ETFs

51.58% Public Companies and

Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 48.37% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 51.58% is owned by Public Companies and Individual Investors.

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 37.89% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 10.48% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$9045774
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$495554
Mar 31, 2024	Western Standard Llc	xxxxxxxxxxxxx	$2347142

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,922,492	Institution	4.01%	33,749,816
	7,304,669	Institution	3.70%	31,117,890
	6,542,392	Institution	3.31%	27,870,590
	3,833,797	Institution	1.94%	16,331,975
	3,545,161	Institution	1.79%	15,102,386
	2,445,533	Institution	1.24%	10,417,971
Michael Rockefeller	2,010,172	Institution	1.02%	8,563,333
	1,606,012	Institution	0.81%	6,841,611
	1,559,360	Institution	0.79%	6,642,874
	903,143	Institution	0.46%	3,847,389

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
6,542,392	Institution	3.31%	27,870,590
3,833,797	Institution	1.94%	16,331,975
2,445,533	Institution	1.24%	10,417,971
1,606,012	Institution	0.81%	6,841,611
1,559,360	Institution	0.79%	6,642,874
903,143	Institution	0.46%	3,847,389
703,917	Institution	0.36%	2,998,686
484,841	Institution	0.25%	2,065,423
432,384	Institution	0.22%	1,841,956
121,867	Institution	0.06%	519,153

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,811,847	Institution	2.44%	20,209,757
iShares Russell 2000 ETF	3,570,743	Institution	1.81%	15,211,365
SPDR S&P BIOTECH ETF	2,615,936	Institution	1.32%	11,143,887
Vanguard Extended Market ETF	1,743,062	Institution	0.88%	7,320,860
iShares Russell 2000 Growth ETF	1,174,073	Institution	0.59%	5,001,551
iShares Biotechnology ETF	1,112,510	Institution	0.56%	4,739,293
Vanguard Russell 2000 ETF	764,654	Institution	0.39%	3,211,547
Schwab U.S. Small-Cap ETF	735,211	Institution	0.37%	3,131,999
SPDR S&P Kensho New Economies Composite ETF	623,896	Institution	0.32%	2,657,797
Vanguard Health Care ETF	429,058	Institution	0.22%	1,802,044

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?

According to the latest TipRanks data, approximately 28.16% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 51.58% is held by retail investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 28.16% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?

According to the latest TipRanks data, approximately 51.58% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.

Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?

Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.